Regulatory Advocacy

The AAO-HNS has a long history of working closely with regulatory agencies (e.g., Centers for Medicare & Medicaid Services, U.S. Food and Drug Administration) to maintain our visibility and credibility with national representatives regarding federal regulatory issues.

We believe that advocacy is the key to defining the future of otolaryngology. Federal regulatory advocacy is a top priority of the AAO-HNS.

Academy Comments on the MACRA RFI
Using feedback solicited from key Academy leaders, the Academy has submitted comments on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Request for Information (RFI). The RFI primarily consists of questions concerning the implementation process for the new Merit-Based Incentive Payment System (MIPS) and eligible Alternative Payment Models (APMs). We anticipate that the newly created MIPS program will significantly impact otolaryngologists and will follow this matter closely. 

Read the comments